221 related articles for article (PubMed ID: 8330399)
41. Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 2. Cross-reactivity of the antisera with cyclosporine metabolites.
Lensmeyer GL; Wiebe DA; Carlson IH; deVos DJ
Clin Chem; 1990 Jan; 36(1):119-23. PubMed ID: 2297901
[TBL] [Abstract][Full Text] [Related]
42. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
43. Noninterchangeability of specific radioimmunoassay and monoclonal antibody fluorescent polarization immunoassay in cyclosporine measurements.
Pape D; Vernillet L; Bellissant E; Bentue-Ferrer D; Allain H
Fundam Clin Pharmacol; 1996; 10(5):484-9. PubMed ID: 8902552
[TBL] [Abstract][Full Text] [Related]
44. HPLC method for monitoring SDZ PSC 833 in whole blood.
Scott MG; Hock KG; Crimmins DL; Fracasso PM
Clin Chem; 1997 Mar; 43(3):505-10. PubMed ID: 9068595
[TBL] [Abstract][Full Text] [Related]
45. Liquid chromatography-tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation.
Moes DJ; Press RR; de Fijter JW; Guchelaar HJ; den Hartigh J
Ther Drug Monit; 2010 Aug; 32(4):413-9. PubMed ID: 20535052
[TBL] [Abstract][Full Text] [Related]
46. Considerable lack of agreement between S-FPIA and EMIT cyclosporine assay in therapeutic drug monitoring, of heart transplant recipients.
Regazzi MB; Molinaro M; Tinelli C; D'Eril GM; Goggi C; Campana C; Fiorito V; Moratti R; Viganò M
Ther Drug Monit; 2000 Dec; 22(6):712-5. PubMed ID: 11128239
[TBL] [Abstract][Full Text] [Related]
47. The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
Khoschsorur G; Auer T; Lanzer G; Petritsch P; Holzer H; Tscheliessnigg KH
Angiology; 1998 Apr; 49(4):307-14. PubMed ID: 9555934
[TBL] [Abstract][Full Text] [Related]
48. An evaluation of the cyclosporine and metabolites whole blood TDx assay.
Schroeder TJ; Pesce AJ; Hindenlang LL; Mauser PA; Ruckrigl DL; Weibel ML; Wadih G; First MR
Ther Drug Monit; 1989; 11(4):480-2. PubMed ID: 2662481
[TBL] [Abstract][Full Text] [Related]
49. Cyclosporine blood concentrations determined by different assay methods in heart transplant patients.
Zylber-Katz E; Granit L
Ther Drug Monit; 1989 Sep; 11(5):592-7. PubMed ID: 2815235
[TBL] [Abstract][Full Text] [Related]
50. Nonselective measurement of cyclosporine for therapeutic drug monitoring by fluorescence polarization immunoassay with a rabbit polyclonal antibody: I. Evaluation of the serum methodology and comparison with a sheep polyclonal antibody in an 3H-tracer mediated radioimmunoassay.
Napoli KL; Kahan BD
Transplant Proc; 1990 Jun; 22(3):1175-80. PubMed ID: 2190377
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the Incstar Cyclo-Trac sp kit for the determination of cyclosporine in blood.
Plebani M; Masiero M; Paleari CD; Faggian D; Burlina A
Clin Biochem; 1989 Oct; 22(5):345-7. PubMed ID: 2805337
[TBL] [Abstract][Full Text] [Related]
52. Comparison of cyclosporin A measurement in whole blood by six different methods.
Tjandra-Maga B; Verbesselt R; Scharpé S; Verkerk R; Lambert WE; Van Liedekerke B; De Leenheer A
J Clin Chem Clin Biochem; 1990 Jan; 28(1):53-7. PubMed ID: 2313238
[TBL] [Abstract][Full Text] [Related]
53. The specificity of monoclonal fluorescence polarization immunoassay for cyclosporine in recipients of simultaneous pancreas-kidney transplants.
Kaplan B; Wang Z; Keilani T; Kaufman DB
Ther Drug Monit; 1995 Oct; 17(5):499-503. PubMed ID: 8585113
[TBL] [Abstract][Full Text] [Related]
54. An evaluation of the cyclosporine parent-compound-specific whole blood TDx assay.
Pescovitz MD; Book BK; Pollard SG; Milgrom ML; Leapman SB; Filo RS
Clin Transplant; 1992 Feb; 6(1):43-7. PubMed ID: 10147649
[TBL] [Abstract][Full Text] [Related]
55. Homogenous enzyme immunoassay for cyclosporine in whole blood using the EMIT 2000 cyclosporine specific assay with the COBAS MIRA-plus analyzer.
Kimura S; Iyama S; Yamaguchi Y; Kanakura Y
J Clin Lab Anal; 2001; 15(6):319-23. PubMed ID: 11793432
[TBL] [Abstract][Full Text] [Related]
56. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay.
Butch AW; Fukuchi AM
J Anal Toxicol; 2004 Apr; 28(3):204-10. PubMed ID: 15107152
[TBL] [Abstract][Full Text] [Related]
57. A modified fluorescence polarization immunoassay method incorporating fat emulsion (FE-FPIA) to determine cyclosporin A concentrations in rat skin.
Kurosaki Y; Asada T; Yasumoto N; Nakamura T; Masada M; Kawasaki H
Biol Pharm Bull; 1999 May; 22(5):539-42. PubMed ID: 10375179
[TBL] [Abstract][Full Text] [Related]
58. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood.
Yatscoff RW; Copeland KR; Faraci CJ
Clin Chem; 1990 Nov; 36(11):1969-73. PubMed ID: 2242580
[TBL] [Abstract][Full Text] [Related]
59. Comparison of cyclosporine blood levels measured by radioimmunoassay and TDx assay using monoclonal antibodies.
Klotz U
Ther Drug Monit; 1991 Sep; 13(5):461-3. PubMed ID: 1957340
[TBL] [Abstract][Full Text] [Related]
60. Specific enzyme-multiplied immunoassay and fluorescence polarization immunoassay for cyclosporin compared with Cyclotrac [125I]radioimmunoassay.
Morris RG; Saccoia NC; Ryall RG; Peacock MK; Sallustio BC
Ther Drug Monit; 1992 Jun; 14(3):226-33. PubMed ID: 1412609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
